Blog
Bioscience Bulletin – Nov 9, 2025
Last week was an active week for health policy! Our Founder and CEO, Liz Powell, Esq., MPH attended the Milken Institute Future of Health Summit, in Washington, D.C.. She participated in the
Read MoreBioscience Bulletin
The shutdown that began on October 1 continues with no end in sight. Most Congressional Democrats refuse to support a bill to re-open the government without an extension of the Affordable Care Act subsidies, which is supported by 78% of the public according to polling by KFF.
Read MoreMHSRS Report 2025
Download our report to see the insights from MHSRS 2025
Read MoreWomen’s Health Capitol Hill Day
Mainstreaming Women’s Health in Congress
Read MoreUpdates on FY25 Budget
We wanted to provide an update on recent developments in Washington around the FY25 budget and Trump Administration actions.
Read MoreWhat’s at Stake in the Election
Before leaving DC on September 27, Congress focused on bills that reinforce party messaging, which they believe will resonate with their base, while avoiding issues that could alienate their voters and put their candidates in contentious positions.
Read MoreMHSRS Report 2024
Download our report to see the insights from MHSRS 2024
Read More2nd Annual Government Biotechnology Innovation Summit
G2G attended the Second Annual Government Biotechnology Innovation Summit from September 4-5
Read MoreFinal TCET Rulemaking
The TCET program is focused on (1) facilitating early, predictable, and safer beneficiary access to new technologies; (2) reducing uncertainty about coverage by evaluating early the potential benefits and harms of technologies with manufacturers; and (3) encouraging evidence development if notable evidence gaps exist for coverage purposes.
Read MoreMHSRS 2024 DAILY DIGEST – DAY 4
The fourth and final day of MHSRS.
Read More